Previous studies on bladder cancer, prostate cancer, renal cancer, and colorectal cancer had reported that the level of CD8+ T cell infiltration was positively correlated with tumor prognosis and responsiveness to immunotherapy (39–41). The gene discussed is CD8A; the disease is neoplasm.